|
"hsu jta"的相關文件
顯示項目 26-75 / 88 (共2頁)
1 2 > >>
每頁顯示[10|25|50]項目
| 國家衛生研究院 |
2014-05 |
Cover Picture: Facile identification of dual FLT3–aurora a inhibitors: A computer-guided drug design approach (ChemMedChem 5/2014)
|
Chang Hsu, Y;Ke, YY;Shiao, HY;Lee, CC;Lin, WH;Chen, CH;Yen, KJ;Hsu, JTA;Chang, C;Hsieh, HP |
| 國家衛生研究院 |
2014-02 |
Epstein-Barr virus BALF3 has nuclease activity and mediates mature virion production during the lytic cycle
|
Chiu, SH;Wu, MC;Wu, CC;Chen, YC;Lin, SF;Hsu, JTA;Yang, CS;Tsai, CH;Takada, K;Chen, MR;Chen, JY |
| 國家衛生研究院 |
2014-01-08 |
Evaluation of the antitumor effects of BPR1J-340, a potent and selective FLT3 inhibitor, alone or in combination with an HDAC inhibitor, vorinostat, in AML cancer
|
Lin, WH;Yeh, TK;Jiaang, WT;Yen, KJ;Chen, CH;Huang, CT;Yen, SC;Hsieh, SY;Chou, LH;Chen, CP;Chiu, CH;Kao, LC;Chao, YS;Chen, CT;Hsu, JTA |
| 國家衛生研究院 |
2013-12 |
Evolutionarily conserved residues at an oligomerization interface of the influenza A virus neuraminidase are essential for viral survival
|
Mok, CK;Chen, GW;Shih, KC;Gong, YN;Lin, SJ;Horng, JT;Hsu, JTA;Chen, CJ;Shih, SR |
| 國家衛生研究院 |
2013-09-22 |
A novel Aurora-A inhibitor, BPR1K0609S1, sensitizes colorectal tumor cells to 5-fluorofracil (5-FU) treatment [Erratum:International Journal of Biological Sciences. 2013 Apr 29;9(4):403-411]
|
Shionome, Y;Lin, WH;Shiao, HY;Hsieh, HP;Hsu, JTA;Ouchi, T |
| 國家衛生研究院 |
2013-06 |
Discovery of 3-phenyl-1H-5-pyrazolylamine derivatives containing a urea pharmacophore as potent and efficacious inhibitors of FMS-like tyrosine kinase-3 (FLT3)
|
Lin, WH;Hsu, JTA;Hsieh, SY;Chen, CT;Song, JS;Yen, SC;Hsu, T;Lu, CT;Chen, CH;Chou, LH;Yang, YN;Chiu, CH;Chen, CP;Tseng, YJ;Yen, KJ;Yeh, CF;Chao, YS;Yeh, TK;Jiaang, WT |
| 國家衛生研究院 |
2013-04-29 |
A novel Aurora-A inhibitor, BPR1K0609S1, sensitizes colorectal tumor cells to 5-fluorofracil (5-FU) treatment
|
Shionome, Y;Lin, WH;Shiao, HY;Hsieh, HP;Hsu, JTA;Ouchi, T |
| 國家衛生研究院 |
2013-04-07 |
BPR000K, a novel Aurora kinase inhibitor
|
Chao, YS;Hsu, JTA;Chen, CT;Yeh, TK;Pan, SL;Hsieh, HP |
| 國家衛生研究院 |
2013-04-07 |
3D-QSAR assisted drug design: Identification of a potent quinazoline based Aurora kinase inhibitor
|
Ke, YY;Shiao, HY;Hsu, YC;Chang-Chu, Y;Wang, WC;Lee, YC;Lin, WH;Hsu, JTA;Chang, CW;Lin, CW;Yeh, TK;Chao, YS;Coumar, MS;Hsieh, HP |
| 國家衛生研究院 |
2013-04-07 |
Development drug candidate targeting EGFR kinase: DBPR112
|
Sun, HY;Hsu, JTA;Chen, CT;Yeh, TK;Pan, SL;Chao, YS;Hsieh, HP |
| 國家衛生研究院 |
2013-04 |
Design and synthesis of Aurora kinase inhibitors as anticancer agents
|
Hsu, YC;Shiao, HY;Lin, WH;Hsu, JTA;Chen, CT;Chao, YS;Hsieh, HP |
| 國家衛生研究院 |
2013-01 |
3D-QSAR-assisted drug design: Identification of a potent quinazoline-based aurora kinase inhibitor
|
Ke, YY;Shiao, HY;Hsu, YC;Chu, CY;Wang, WC;Lee, YC;Lin, WH;Chen, CH;Hsu, JTA;Chang, CW;Lin, CW;Yeh, TK;Chao, YS;Coumar, MS;Hsieh, HP |
| 國家衛生研究院 |
2012-12 |
An efficient, mild and scalable synthesis of bioactive compounds containing the angelicin scaffold
|
Shiao, HY;Kuo, CC;Horng, JT;Shih, SR;Chang, SY;Liao, CC;Hsu, JTA;Kumar, AP;Chao, YS;Hsieh, HP |
| 國家衛生研究院 |
2012-11 |
BPR1J271, a novel FLT3 inhibitor for treating acute myeloid leukemia
|
Chen, CT;Lin, WH;Chou, LH;Chen, CP;Yen, SC;Huang, YL;Yeh, TK;Hsu, JTA;Jiaang, WI;Chao, YS |
| 國家衛生研究院 |
2012-03-25 |
Design, synthesis, and SAR studies of duel FLT-3 and Aurora kinase inhibitors
|
Hsieh, HP;Shiao, HY;Lin, WH;Hsu, JTA;Chao, YS |
| 國家衛生研究院 |
2011-03-27 |
Design and synthesis of potent Aurora kinase inhibitors
|
Chu, CY;Mohane, CS;Hsu, JTA;Yeh, TK;Chen, CT;Chao, YS;Hsieh, HP |
| 國家衛生研究院 |
2011-03 |
Potent EGFR tyrosine kinase inhibitors as anticancer agents
|
Shiao, HY;Chu, CY;Hsu, JTA;Yeh, TK;Hsieh, HP |
| 國家衛生研究院 |
2010-04 |
Inhibition of enterovirus 71 replication and the viral 3D polymerase by aurintricarboxylic acid
|
Hung, HC;Chen, TC;Fang, MY;Yen, KJ;Shih, SR;Hsu, JTA;Tseng, CP |
| 國家衛生研究院 |
2010-02-23 |
Pyrazole compound BPR1P0034 with potent and selective anti-influenza virus activity
|
Shih, SR;Chu, TY;Reddy, GR;Tseng, SN;Chen, HL;Tang, WF;Wu, MS;Yeh, JY;Chao, YS;Hsu, JTA;Hsieh, HP;Horng, JT |
| 國家衛生研究院 |
2010-02-01 |
Identification, SAR studies, and X-ray Co-crystallographic analysis of a novel furanopyrimidine aurora kinase a inhibitor
|
Coumar, MS;Tsai, MT;Chu, CY;Uang, BJ;Lin, WH;Chang, CY;Chang, TY;Leou, JS;Teng, CH;Wu, JS;Fang, MY;Chen, CH;Hsu, JTA;Wu, SY;Chao, YS;Hsieh, HP |
| 國家衛生研究院 |
2009-09 |
Fast-forwarding kinase drug discovery: aurora and EGFR kinase inhibitor lead development
|
Hsieh, HP;Coumarrs, MS;Chu, CY;Ho, YL;Tsai, MT;Lin, WH;Chen, CH;Song, JS;Hsu, JTA;Chao, YS |
| 國家衛生研究院 |
2009-02-26 |
Structure-based drug design of novel aurora kinase a inhibitors: Structural basis for potency and specificity
|
Coumar, MS;Leou, JS;Shukla, P;Wu, JS;Dixit, AK;Lin, WH;Chang, CY;Lien, TW;Tan, UK;Chen, CH;Hsu, JTA;Chao, YS;Wu, SY;Hsieh, HP |
| 國家衛生研究院 |
2009-02 |
Aurintricarboxylic acid inhibits influenza virus neuraminidase
|
Hung, HC;Tseng, CP;Yang, JM;Ju, YW;Tseng, SN;Chen, YF;Chao, YS;Hsieh, HP;Shih, SR;Hsu, JTA |
| 國家衛生研究院 |
2008-12 |
Mana-Hox displays anticancer activity against prostate cancer cells through tubulin depolymerization and DNA damage stress
|
Hsiao, CJ;Ho, YF;Hsu, JTA;Chang, WL;Chen, YC;Shen, YC;Lyu, PC;Guh, JH |
| 國家衛生研究院 |
2008-08-01 |
Design, synthesis, and evaluation of 3C protease inhibitors as anti-enterovirus 71 agents
|
Kuo, CJ;Shie, JJ;Fang, JM;Yen, GR;Hsu, JTA;Liu, HG;Tseng, SN;Chang, SC;Lee, CY;Shih, SR;Liang, PH |
| 國家衛生研究院 |
2008-07 |
Anti-HSV activity of digitoxin and its possible mechanisms
|
Su, CT; Hsu, JTA; Hsieh, HP; Lin, PH; Chen, TC; Kao, CL; Lee, CN; Chang, SY |
| 國家衛生研究院 |
2008-06-01 |
A cell-based high-throughput screen for epidermal growth factor receptor pathway inhibitors
|
Lin, WH; Song, JS; Chang, TY; Chang, CY; Fu, YN; Yeh, CL; Wu, SH; Huang, YW; Fang, MY; Lien, TW; Hsieh, HP; Chao, YS; Huang, SF; Tsai, SF; Wang, LM; Hsu, JTA; Chen, YR |
| 國家衛生研究院 |
2008-05 |
Bioassay-guided purification and identification of PPARa/gamma agonists from Chlorella sorokiniana
|
Chou, YC; Prakash, E; Huang, CF; Lien, TW; Chen, X; Su, IJ; Chao, YS; Hsieh, HP; Hsu, JTA |
| 國家衛生研究院 |
2008-04-01 |
A mammalian cell-based reverse two-hybrid system for functional analysis of 3C viral protease of human enterovirus 71
|
Lee, JC; Shih, SR; Chang, TY; Tseng, HY; Shih, YF; Yen, KJ; Chen, WC; Shie, JJ; Fang, JM; Liang, PH; Chao, YS; Hsu, JTA |
| 國家衛生研究院 |
2008-03-01 |
Aurora kinase A inhibitors: Identification, SAR exploration and molecular modeling of 6,7-dihydro-4H-pyrazolo-[1,5-a]pyrrolo[3,4-d]pyrimidine-5,8-dione scaffold
|
Coumar, MS; Wu, JS; Leou, JS; Tan, UK; Chang, CY; Chang, TY; Lin, WH; Hsu, JTA; Chao, YS; Wu, SY; Hsieh, HP |
| 國家衛生研究院 |
2007-12 |
Strategies of development of antiviral agents directed against influenza virus replication
|
Hsieh, HP;Hsu, JTA |
| 國家衛生研究院 |
2007-09 |
Sf-Caspase-I-repressed stable cells: resistance to apoptosis and augmentation of recombinant protein production
|
Lin, CC; Hsu, JTA; Huang, KL; Tang, HK; Shu, CW; Lai, YK |
| 國家衛生研究院 |
2007-07 |
Anti-influenza drug discovery
|
Hsu, JTA;Hsieh, HP;Hung, HC;Ju, YW;Tseng, SN;Tseng, CP;Yang, JM;Chang, CW;Fang, MY;Lin, CC;Homg, JT;Shih, SR;Chao, YS |
| 國家衛生研究院 |
2007-02-08 |
Isocostunolide, a sesquiterpene lactone, induces mitochondrial membrane depolarization and caspase-dependent apoptosis in human melanoma cells
|
Chen, CN; Huang, HH; Wu, CL; Lin, CPC; Hsu, JTA; Hsieh, HP; Chuang, SE; Lai, GM |
| 國家衛生研究院 |
2006-11-25 |
The inhibitory effect of polyunsaturated fatty acids on human CYP enzymes
|
Yao, HT; Chang, YW; Lan, SJ; Chen, CT; Hsu, JTA; Yeh, TK |
| 國家衛生研究院 |
2006-10-19 |
Structural basis for the structure-activity relationships of peroxisome proliferator-activated receptor agonists
|
Mahindroo, N; Peng, YH; Lin, CH; Tan, UK; Prakash, E; Lien, TW; Lu, IL; Lee, HJ; Hsu, JTA; Chen, X; Liao, CC; Lyu, PC; Chao, YS; Wu, SY; Hsieh, HP |
| 國家衛生研究院 |
2006-07 |
Antiviral drug discovery against SARS-CoV
|
Wu, YS;Lin, WH;Hsu, JTA;Hsieh, HP |
| 國家衛生研究院 |
2006-05-04 |
Structure-based drug design of a novel family of PPAR gamma partial agonists: Virtual screening, X-ray crystallography, and in vitro/in vivo biological activities
|
Lu, IL; Huang, CF; Peng, YH; Lin, YT; Hsieh, HP; Chen, CT; Lien, TW; Lee, HJ; Mahindroo, N; Prakash, E; Yueh, A; Chen, HY; Goparaju, CMV; Chen, X; Liao, CC; Chao, YS; Hsu, JTA; Wu, SY |
| 國家衛生研究院 |
2006-02-09 |
Indol-1-yl acetic acids as peroxisome proliferator-activated receptor agonists: Design, synthesis, structural biology, and molecular docking studies
|
Mahindroo, N; Wang, CC; Liao, CC; Huang, CF; Lu, IL; Lien, TW; Peng, YH; Huang, WJ; Lin, YT; Hsu, MC; Lin, CH; Tsai, CH; Hsu, JTA; Chen, X; Lyu, PC; Chao, YS; Wu, SY; Hsieh, HP |
| 國家衛生研究院 |
2006-02 |
Stable RNA interference in Spodoptera frugiperda cells by a DNA vector-based method
|
Lin, CC; Hsu, JTA; Huang, KL; Tang, HK; Lai, YK |
| 國家衛生研究院 |
2006-01-01 |
Synthesis and anti-viral activity of a series of sesquiterpene lactones and analogues in the subgenomic HCV replicon system
|
Hwang, DR;Wu, YS;Chang, CW;Lien, TW;Chen, WC;Tan, UK;Hsu, JTA;Hsieh, HP |
| 國家衛生研究院 |
2006 |
Antiviral drug discovery targeting to viral proteases
|
Hsu, JTA; Wang, HC; Chen, GW; Shih, SR |
| 國家衛生研究院 |
2005-11 |
Emergence of mutation clusters in the HCV genome during sequential viral passages in Sip-L expressing cells
|
Hwang, DR; Lai, HY; Chang, ML; Hsu, JTA; Yeh, CT |
| 國家衛生研究院 |
2005-10 |
Inhibition of hepatitis C virus replication by antimonial compounds
|
Hwang, DR; Lin, RK; Leu, GZ; Lin, TY; Lien, TW; Yu, MC; Yeh, CT; Hsu, JTA |
| 國家衛生研究院 |
2005-08-02 |
Papain-like protease 2 (PLP2) from severe acute respiratory syndrome coronavirus (SARS-CoV): Expression, purification, characterization, and inhibition
|
Han, YS; Chang, GG; Juo, CG; Lee, HJ; Yeh, SH; Hsu, JTA; Chen, X |
| 國家衛生研究院 |
2005-08 |
High-throughput cell-based screening for hepatitis C virus NS3/4A protease inhibitors
|
Lee, JC; Yu, MC; Lien, TW; Chang, CF; Hsu, JTA |
| 國家衛生研究院 |
2005-06-05 |
High-efficiency protein expression mediated by enterovirus 71 internal ribosome entry
|
Lee, JC; Wu, TY; Huang, CF; Yang, FM; Shih, SR; Hsu, JTA |
| 國家衛生研究院 |
2005-04-22 |
Anti-HCV activities of selective polyunsaturated fatty acids [Erratum: Biochemical and Biophysical Research Communications. 2004 May;318(1):275-280.]
|
Leu, GZ; Lin, TY; Hsu, JTA |
| 國家衛生研究院 |
2005 |
Inhibition of SARS-CoV 3C-like protease activity by theaflavin-3,3 '- digallate (TF3)
|
Chen, CN; Lin, CPC; Huang, KK; Chen, WC; Hsieh, HP; Liang, PH; Hsu, JTA |
| 國家衛生研究院 |
2004-10 |
Biosynthesis of human-type N-glycans in heterollogous systems
|
Betenbaugh, MJ; Tomiya, N; Narang, S; Hsu, JTA; Lee, YC |
顯示項目 26-75 / 88 (共2頁)
1 2 > >>
每頁顯示[10|25|50]項目
|
